中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2015 No. 2

Display Method:
Editorial
Application prospects of research on pathogenesis of primary biliary cirrhosis
Lu FangTing, Lian ZheXiong
2015, 31(2): 153-156. DOI: 10.3969/j.issn.1001-5256.2015.02.001
Abstract:

Primary biliary cirrhosis( PBC) is an autoimmune liver disease characterized by the destruction of small intrahepatic bile ducts.Incomprehensible and complicated autoreactive responses participate in the development and progression of PBC,which involve various immune cells and inflammatory mediators...

Therapeutic guidelines
Acute cholecystitis: WSES position statement
Yu LiMing, He Song, Gao YanHang
2015, 31(2): 157-159. DOI: 10.3969/j.issn.1001-5256.2015.02.002
Abstract:
Discussions by experts
Advances in diagnosis and treatment of autoimmune hepatitis
Wang QianYi, Jia JiDong
2015, 31(2): 160-162. DOI: 10.3969/j.issn.1001-5256.2015.02.003
Abstract:

Autoimmune hepatitis( AIH) is a progressive,chronic hepatitis of unknown cause. It is characterized by interface hepatitis,hypergammaglobulinaemia,circulating autoantibodies,and a favorable response to immunosuppression. This article summarizes the epidemiological and clinical characteristics of AIH...

Research advances in primary biliary cirrhosis
Zhu JiangYi, Han Ying
2015, 31(2): 163-164. DOI: 10.3969/j.issn.1001-5256.2015.02.004
Abstract:

Primary biliary cirrhosis( PBC) is a chronic progressive cholestatic liver disease associated with immunity,with unknown etiology and pathogenesis. This article reviews the origin of its name,recent advances in research on PBC,and the prospect of treatment. Ursodeoxycholic acid is considered to be e...

Epidemiology and natural history of primary biliary cirrhosis
Wang LiFeng, Li YuanYuan, Jin Lei, Wang FuSheng
2015, 31(2): 165-170. DOI: 10.3969/j.issn.1001-5256.2015.02.005
Abstract:

Primary biliary cirrhosis( PBC) is an autoimmune cholestatic liver disease. In this review,the epidemiology of PBC,which varies in different countries and regions,is comprehensively introduced. Furthermore,the natural history of PBC before and after the wide application of ursodeoxycholic acid is an...

Autoimmune sclerosing cholangitis: new concept and new evidence
Han Ying, Zhu JiangYi
2015, 31(2): 171-173. DOI: 10.3969/j.issn.1001-5256.2015.02.006
Abstract:

Sclerosing cholangitis can be divided into primary sclerosing cholangitis( PSC) and secondary sclerosing cholangitis according to the etiology and pathogenesis,and the pathogenesis of PSC may be associated with immunity. In recent years,a new type of sclerosing cholangitis has been found,which is ch...

Research progress in diagnosis and treatment of autoimmune liver disease overlap syndrome
Shang Jia, Ning HuiBin
2015, 31(2): 174-177. DOI: 10.3969/j.issn.1001-5256.2015.02.007
Abstract:

Autoimmune liver disease overlap syndrome is a special type of autoimmune disease,and consensus has not been reached regarding the etiology and diagnosis and treatment. This paper reviews many aspects of overlap syndrome,such as etiology,pathogenesis,diagnosis and treatment,and its development proce...

Original articles_Autoimmune liver diseases
Significance of combined analysis of autoantibodies in diagnosis of primary biliary cirrhosis
Cao ZhangChun
2015, 31(2): 178-180. DOI: 10.3969/j.issn.1001-5256.2015.02.008
Abstract:

Objective To evaluate the significance of combined analysis of different autoantibodies in the diagnosis of primary biliary cirrhosis( PBC). Methods Two- hundred and forty- five patients with liver diseases were randomly selected. According to the disease type,patients were divided into PBC group( n...

Clinical efficacy of Biejiaruangan compound tablets in treatment of primary biliary cirrhosis
Huang LingYing, Zhou ZhenHua, Sun XueHua, Li Man, Zhu XiaoJun, Jin ShuGen, Zhang Xin, Gao YueQiu
2015, 31(2): 181-184. DOI: 10.3969/j.issn.1001-5256.2015.02.009
Abstract:

Objective To evaluate the clinical efficacy of Biejiaruangan compound tablets in the treatment of primary biliary cirrhosis( PBC). Methods In a randomized,double- blind,placebo- controlled study,56 patients with PBC were collected and equally divided into treatment group and control group. The treat...

Correlation between clinical data and pathological stage in patients with primary biliary cirrhosis: a study of 54 cases
Huang ChunYang, Huang YunLi, Liu YanMin, Han Ying, Zhang XiaoDan, Zhao Peng, Liao HuiYu
2015, 31(2): 185-188. DOI: 10.3969/j.issn.1001-5256.2015.02.010
Abstract:

Objective To investigate the correlation between clinical data and pathological stage in patients with primary biliary cirrhosis( PBC) and to provide guidance for clinical diagnosis and treatment. Methods The clinical data of 54 PBC patients were collected for analyzing the correlation between the c...

Analysis of incidence and risk factors for ERCP-related adverse events in patients with primary sclerosing cholangitis
Bi RongXin, Guo QuanZhou, Xue ZhiGuang, Hou ZhiQiang
2015, 31(2): 189-192. DOI: 10.3969/j.issn.1001-5256.2015.02.011
Abstract:

Objective To investigate the incidence and risk factors for endoscopic retrograde cholangiopancreatography( ERCP)- related adverse events in patients with primary sclerosing cholangitis( PSC). Methods This study included 72 patients who were diagnosed with PSC by magnetic resonance cholangiopancreat...

Original articles_Viral hepatitis
Clinical study of pegylated interferon α-2a in treatment of children with HBe Ag-positive chronic hepatitis B
Liu YunHua, Li Zhen, Liu Li, Peng Dan, Li WeiKun, Chang LiXian, Jia Ting, Yang YongRui, Li HuiMin, Wang LiQian
2015, 31(2): 193-197. DOI: 10.3969/j.issn.1001-5256.2015.02.012
Abstract:

Objective To investigate the clinical efficacy of pegylated interferon α- 2a( PEG- IFNα- 2a) in the treatment of children with HBe Ag- positive chronic hepatitis B( CHB). Methods A total of 31 children with CHB aged from 2- 16 years were randomly enrolled in this study and divided into two groups ba...

Significance of Fibro Scan examination in hepatitis B virus-infected patients with normal ALT
Liu HongBo, Wang Ning, Dan Hong, Qin LiLi
2015, 31(2): 198-201. DOI: 10.3969/j.issn.1001-5256.2015.02.013
Abstract:

Objective To screen hepatitis B virus( HBV)- infected patients with normal alanine aminotransferase( ALT) using Fibro Scan( FS). Methods Liver biopsy was done for all the 125 patients who were admitted to our hospitals from November 2012 to November 2013,and FS was performed for the liver stiffness ...

Efficacy of thymosin α1 in chronic HBV infection patients with low viral load in immune-clearance or low-replication phase
Sun JianMin
2015, 31(2): 202-204. DOI: 10.3969/j.issn.1001-5256.2015.02.014
Abstract:

Objective To study the efficacy of thymosin α1 in the treatment of chronic hepatitis B virus( HBV) infection with low viral load. Method Seventy- six patients with low- viral load chronic HBV infection admitted to our hospital from June 2011 to June 2013 were randomly assigned to treatment group,and...

Regulatory effect of gamma-chain cytokines on expression of TIM-3 on CD8~+T cells in patients with chronic hepatitis B
Dong Jie, Yang XiaoFei, Shen HuanJun, Zhao RongRong, Zhao YanYan, Zhang Ye, Huang ZhangXing, Lian JianQi
2015, 31(2): 205-208. DOI: 10.3969/j.issn.1001-5256.2015.02.015
Abstract:

Objective To measure the expression of T- cell immunoglobulin- and mucin domain- 3- containing molecule 3( TIM- 3)on CD8+T cells in peripheral blood mononuclear cells( PBMCs) among patients with chronic hepatitis B( CHB) and to investigate the effect of common gamma- chain cytokines on the expressio...

Original articles_Liver fibrosis and liver cirrhosis
Value of single or combined measurement of serum PCT,peripheral WBC,and WBC/PCT for early diagnosis of bacterial infection in patients with liver cirrhosis
Zheng JunFu, Cai ZhaoHua, Zhang Xin, Lou JinLi, Zhao WenMin, Li Peng, Li Bing, Li Lei, Dong PeiLing, Ding HuiGuo
2015, 31(2): 209-213. DOI: 10.3969/j.issn.1001-5256.2015.02.016
Abstract:

Objective To investigate the early diagnostic value of single or combined measurement of serum procalcitonin( PCT),peripheral white blood cells( WBC),and ratio of WBC to platelets( PLT)( WBC / PLT) for spontaneous bacterial peritonitis( SBP) in patients with liver cirrhosis. Methods The clinical dat...

Individual and combined effects of octreotide and terlipressin on hepatic venous pressure gradient in cirrhotic patients
Xia YuLian, Zhang ChunQing, Wang GuangChuan, Feng Hua, Zhang MingYan
2015, 31(2): 214-218. DOI: 10.3969/j.issn.1001-5256.2015.02.017
Abstract:

Objective The administration of octreotide,as well as terlipressin,is a routine treatment for acute variceal bleeding in cirrhotic patients. This study aimed to evaluate the effects of octreotide,terlipressin,and their combination on hepatic venous pressure gradient( HVPG) in cirrhotic patients. Met...

Comparison of hepatic fibrosis models and associated hepatic fibronectin expression in Wistar rats treated by bile duct ligation and CCl4
Liu XiaoYa, Liu RuiXia, Cui LiJian, Hou Fei, Wen Yan, Yin ChengHong
2015, 31(2): 219-224. DOI: 10.3969/j.issn.1001-5256.2015.02.018
Abstract:

Objective To compare serum biochemical parameters,liver pathology,and fibronectin( FN) expression in Wister rats with hepatic fibrosis induced by bile duct ligation( BDL) and carbon tetrachloride( CCl4). Methods Ninety healthy male Wister rats were assigned to CCl4model( n = 44),CCl4control( n = 6),...

Original articles_Liver neoplasms
Survival analysis of intrahepatic arterial infusion of Endostar combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma
Liu Qi, Wu ZhenMing, Qi XiuHeng, Guo Qian
2015, 31(2): 225-227. DOI: 10.3969/j.issn.1001-5256.2015.02.019
Abstract:

Objective To assess the efficacy of intrahepatic arterial infusion of Endostar( rh- endostatin,YH- 16) combined with transcatheter arterial chemoembolization( TACE) for the treatment of advanced hepatocellular carcinoma( a HCC). Methods The study enrolled 76 a HCC patients who were admitted to and t...

Analysis of risk factors for early recurrence after microwave ablation for primary hepatocellular carcinoma
Hu CaiXia, Zheng JiaSheng, Lin Wei, Cui ShiChang
2015, 31(2): 228-231. DOI: 10.3969/j.issn.1001-5256.2015.020
Abstract:

Objective To investigate the relevant risk factors for early recurrence after microwave ablation for primary hepatocellular carcinoma( HCC),and to provide a reference for predicting and preventing tumor recurrence. Methods A retrospective analysis was conducted on the clinical data of 80 patients wh...

Value of serum GP73,AFP,and AFP-L3 in diagnosis of liver cancer and recurrence monitoring after radiofrequency ablation
Zhang Qin, Dan HongLi, Xu Wei
2015, 31(2): 232-235. DOI: 10.3969/j.issn.1001-5256.2015.02.021
Abstract:

Objective To explore the clinical value of three serum tumor markers,Golgi protein 73( GP73),alpha- fetoprotein( AFP),and AFP- L3,in the diagnosis of liver cancer and recurrence monitoring after radio frequency ablation. Methods A total of 174 patients who visited our hospital from July 2012 to Octo...

Curative effect and prognostic impact of radical resection assisted by transcatheter arterial chemoembolization in treatment of intrahepatic cholangiocarcinoma
Tang Xiao
2015, 31(2): 236-239. DOI: 10.3969/j.issn.1001-5256.2015.02.022
Abstract:

Objective To investigate the curative effect and prognostic impact of radical resection assisted by transcatheter arterial chemoembolization( TACE) in the treatment of intrahepatic cholangiocarcinoma( ICC). Methods The clinical data of 80 patients with ICC who were admitted to the Department of Hepa...

Association of ERα-29 gene polymorphisms with susceptibility to HBV-related hepatocellular carcinoma
Zhou Ning, Zhang YueRong, Wei ShiFang, Li XiangLin, Wu LiYang
2015, 31(2): 240-243. DOI: 10.3969/j.issn.1001-5256.2015.02.023
Abstract:

Objective To evaluate the relationship between estrogen receptor- α- 29( ERα- 29) gene polymorphisms and the development of HBV- related hepatocellular carcinoma( HCC) in Gansu Province,China,and to investigate the pathogenesis of HCC at the gene level. Methods Gene polymorphisms of ERα- 29 were ana...

Expression of NOTCH4 affects vasculogenic mimicry formation in hepatocellular carcinoma
Cheng Rui, Ke Kun, Cai XinRan, Zhou HaoHui, Chen YanLing
2015, 31(2): 244-247. DOI: 10.3969/j.issn.1001-5256.2015.02.024
Abstract:

Objective To investigate the effect of NOTCH4 expression on vasculogenic mimicry( VM) formation in hepatocellular carcinoma( HCC). Methods Tumor tissues were collected from 85 patients diagnosed with HCC. The relationship between NOTCH4 expression and VM was examined using immunohistochemical staini...

Role of Peg10 in FAK-mediated CAM-DR in hepatocellular carcinoma
Zhang Hai, Chang Cheng, Zhu YanLi, Li Dan, Zhang Li, Yu LiQun, Fang ChunHua, Hu YaHua
2015, 31(2): 248-252. DOI: 10.3969/j.issn.1001-5256.2015.02.025
Abstract:

Objective To preliminarily investigate the relationship of Peg10 with focal adhesion kinase( FAK)- mediated cell adhesion-mediated drug resistance( CAM- DR) in hepatocellular carcinoma( HCC),and to explore the underlying molecular mechanism. Methods The effects of 5- fluorouracil( 5- Fu) and adriamy...

Original articles_Others
Application of thromboelastography in patients after liver transplantation
Yuan HongXiang, Zhang RuiJin, Qi Mei, Yu YanHua, Lou JinLi
2015, 31(2): 253-255. DOI: 10.3969/j.issn.1001-5256.2015.02.026
Abstract:

Objective To evaluate the value of thromboelastography( TEG) in guiding the proper use of blood components in patients after liver transplantation. Methods The blood samples from 35 patients after liver transplantation who visited our hospital from November 2013 to April 2014 were collected,in which...

Relationship between alcoholic fatty liver disease and carotid intima-media thickness and influencing factors for carotid intima-media thickness
Qu BaoGe, Wang Hui, Su JiLiang, Wang ZhongDong, Wang YaFei, Han XinHai, Liu YuanXun, Jia YiGuo, Pan JinDun, Ren GuangYing
2015, 31(2): 256-260. DOI: 10.3969/j.issn.1001-5256.2015.02.027
Abstract:

Objective To assess the relationship between alcoholic fatty liver disease( AFLD) and carotid intima- media thickness( CIMT) and the influencing factors for CIMT. Methods A cross- sectional study was conducted in 147 males who were inpatients or had physical examination at the Taishan Hospital in Sh...

Effects of niacin on lipid metabolism in rat model of non-alcoholic fatty liver disease
Chen Jing, Jiang YingAn
2015, 31(2): 261-265. DOI: 10.3969/j.issn.1001-5256.2015.02.028
Abstract:

Objective To investigate the effects of niacin on the lipid metabolism in rat model of non- alcoholic fatty liver disease( NAFLD). Methods Forty Sprague- Dawley rats were randomly divided into control group,model group,intervention group 1( 0. 5%niacin),and intervention group 2( 1% niacin). Rats wer...

Brief reports
Efficacy of adefovir dipivoxil in treatment of chronic hepatitis B patients with non-alcoholic fatty liver disease
Xiao ChunHua, Li XuHui, Zhang ChunLan, Jian XiYao
2015, 31(2): 266-268. DOI: 10.3969/j.issn.1001-5256.2015.02.029
Abstract:
Case reports
A case of primary biliary cirrhosis complicated by dermatomyositis without dermatitis
Wang WeiYan, Yang Jing, Lu Shuang, Ceng JingZhang
2015, 31(2): 269-272. DOI: 10.3969/j.issn.1001-5256.2015.030
Abstract:
Neutropenia caused by telbivudine in chronic hepatitis B patients: a report of one case
Wang RongQi, Nan YueMin
2015, 31(2): 273-274. DOI: 10.3969/j.issn.1001-5256.2015.02.031
Abstract:
Successful treatment of thrombocytopenia associated with chronic viral hepatitis: a report of two cases and literature review
Sun Jing, Wang JingYun, Li QingQuan, Lu: MeiDe, Gao YanHang
2015, 31(2): 275-277. DOI: 10.3969/j.issn.1001-5256.2015.02.032
Abstract:
Liver cirrhosis with severe lactic acidosis: an analysis of 2 cases
Lu: YongHao, Wen WeiQin, Ceng JingJing, Hu XiaoHua, Rao KeHan, Xiang FengMei
2015, 31(2): 278-279. DOI: 10.3969/j.issn.1001-5256.2015.02.033
Abstract:
One case of myelofibrosis with cirrhotic portal hypertension
Zhang Li, Fu XiaoXia, Li Xun
2015, 31(2): 280-281. DOI: 10.3969/j.issn.1001-5256.2015.02.034
Abstract:
Misdiagnosis of primary peritoneal malignant mesothelioma in one case
Li WenLin, Wang ChunHong
2015, 31(2): 282-283. DOI: 10.3969/j.issn.1001-5256.2015.02.035
Abstract:
Cellular neurothekeoma of hepatoduodenal ligament: a report of one case
Chen Yu, Liu YaHui
2015, 31(2): 284-285. DOI: 10.3969/j.issn.1001-5256.2015.02.036
Abstract:
One case of Wilson′s disease in adults with right knee joint gall as initial symptom
He Na, Wang Jun, Zhao LongBin, Wu KaiChun, Zhou XinMin
2015, 31(2): 286-287. DOI: 10.3969/j.issn.1001-5256.2015.02.037
Abstract:
Reviews
Research advances in pathogenesis of liver steatosis in chronic hepatitis C
Wei FangFang, Zhang XiaoHong
2015, 31(2): 288-290. DOI: 10.3969/j.issn.1001-5256.2015.02.038
Abstract:

Liver steatosis is a frequent histological feature in patients with chronic hepatitis C( CHC),and it is associated with the progression of CHC and antiviral efficacy. This paper reviews recent research advances in the viral and host factors involved in the pathogenesis of steatosis among CHC patient...

Mechanism of iron metabolism disorder in patients with chronic hepatitis C
Qin Yuan, Guo YongHong, Zhang Ying, Jia ZhanSheng
2015, 31(2): 291-294. DOI: 10.3969/j.issn.1001-5256.2015.02.039
Abstract:

Since the liver is the major iron storage organ in human body,iron metabolism disorder is closely related to chronic hepatitis. So far,the mechanisms underlying iron overload in chronic hepatitis C( CHC) have not been fully elucidated. Highly complex regulation of hepcidin relies on a number of vari...

Recent research findings on non-invasive diagnosis of liver fibrosis
Wu Qiong, Xu GuangHua
2015, 31(2): 295-299. DOI: 10.3969/j.issn.1001-5256.2015.02.040
Abstract:

Early diagnosis of liver fibrosis and dynamic monitoring of relevant changes have great implications for the treatment and prognosis improvement of chronic liver diseases. So far,liver biopsy remains the“golden standard”for the diagnosis and staging of liver fibrosis. However,due to its inherent lim...

Research advances in Hedgehog signaling pathway in hepatocellular carcinoma
Liu Jia, Zhu QinMei, Hu HongYi, Wang Su
2015, 31(2): 300-304. DOI: 10.3969/j.issn.1001-5256.2015.02.041
Abstract:

Hedgehog( Hh) signaling pathway is present in many animals and plays an important role in regulating embryonic development and differentiation. Aberrant activation of Hh signaling contributes to the pathogenesis of many malignancies. Recent studies have shown that dysregulated Hh signaling pathway p...

Research advances in diagnosis and treatment of adult hepatoblastoma
Yang Jie, Du ChengYou
2015, 31(2): 305-309. DOI: 10.3969/j.issn.1001-5256.2015.02.042
Abstract:

Adult hepatoblastoma is extremely rare in clinical practice,and its pathogenesis is unknown. At present,there is a lack of understanding of this disease,and therefore clinical misdiagnosis is common. This review introduces the pathogenesis,clinical manifestations,and radiological and pathological ch...

Significance of factor Ⅱ G20210A mutation in Budd-Chiari syndrome and portal vein thrombosis
Zhang WenWen, Qi XingShun, Guo XiaoZhong
2015, 31(2): 310-314. DOI: 10.3969/j.issn.1001-5256.2015.02.043
Abstract:

Budd- Chiari syndrome( BCS) is characterized by the hepatic outflow obstruction from the small hepatic vein to the superior hepatic inferior vena cava. Portal vein thrombosis( PVT) refers to the development of thrombosis in the main portal vein,with or without thrombosis in the superior mesenteric o...

New advances in pharmacological mechanism of silymarin and re-investigation of its clinical values
Li QingQuan, Zhou Qiang, Niu JunQi, Gao YanHang
2015, 31(2): 315-317. DOI: 10.3969/j.issn.1001-5256.2015.02.044
Abstract:

Silymarin is a traditional hepatoprotective herb for the adjuvant therapy of liver diseases,which shows marked pharmacological activities such as antioxidant and anti- inflammatory properties. This paper introduces the action mechanism of silymarin in regulating liver function,ameliorating hepatic f...